OPNT - Opiant Pharmaceuticals to Participate in 32nd Oppenheimer Healthcare Conference

March, 10 2022 04:01 PM Opiant Pharmaceuticals Inc.

SANTA MONICA, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (Nasdaq: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that its Chief Executive Officer, Dr. Roger Crystal, will participate in a fireside chat at the 32 ^nd Annual Oppenheimer Healthcare Conference taking place virtually March 15 - March 17. Management will also host investor 1x1 meetings.

32 ^nd Oppenheimer Annual Oppenheimer Healthcare Conference
March 15 – 17, 2022
Fireside chat on March 16 at 2:40 pm ET; hosting 1-on-1 meetings

A webcast of the presentation will be accessible on the Opiant website .

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN ^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com

Company Name:	Opiant Pharmaceuticals Inc.
Stock Symbol:	OPNT
Market:	NASDAQ